These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31366152)

  • 1. Angiogenesis, Lymphangiogenesis, and the Immune Response in South African Preeclamptic Women Receiving HAART.
    Naicker T; Phoswa WN; Onyangunga OA; Gathiram P; Moodley J
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366152
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers.
    Phoswa WN; Naicker T; Ramsuran V; Moodley J
    Inflamm Res; 2019 Jan; 68(1):47-57. PubMed ID: 30276649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal Th1/Th2 cytokines in preeclampsia and HIV-positive preeclamptic women on highly active anti-retroviral therapy.
    Pillay P; Moodley K; Vatish M; Moodley J; Duarte R; Mackraj I
    Cytokine; 2020 Jan; 125():154795. PubMed ID: 31398625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
    Maharaj NR; Phulukdaree A; Nagiah S; Ramkaran P; Tiloke C; Chuturgoon AA
    PLoS One; 2017; 12(1):e0170063. PubMed ID: 28095491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART.
    Maharaj NR; Ramkaran P; Pillay S; Chuturgoon AA
    BMC Genet; 2017 Jan; 18(1):5. PubMed ID: 28103790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
    Sebitloane HM; Moodley D
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental leptin in HIV-associated preeclampsia.
    Haffejee F; Naicker T; Singh M; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):271-6. PubMed ID: 24139888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-27a rs895819 is associated with obesity in HIV infected preeclamptic Black South African women on HAART.
    Maharaj NR; Ramkaran P; Pillay S; Chuturgoon AA
    BMC Med Genet; 2016 Dec; 17(1):92. PubMed ID: 27919232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does HAART dysregulate angiogenesis in HIV infected preeclampsia?
    Padayachee S; Govender N; Naicker T
    Niger J Physiol Sci; 2022 Jun; 37(1):29-34. PubMed ID: 35947837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Highly Active Antiretroviral Therapy (HAART) on Interleukin 17A (IL-17A) in Normotensive and Preeclamptic Black South African Women.
    Phoswa WN; Naicker T; Ramsuran V; Moodley J
    Infect Dis Obstet Gynecol; 2020; 2020():3417632. PubMed ID: 32550763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Preeclampsia in Human Immunodeficiency Virus-Infected Pregnant Women.
    Sansone M; Sarno L; Saccone G; Berghella V; Maruotti GM; Migliucci A; Capone A; Martinelli P
    Obstet Gynecol; 2016 Jun; 127(6):1027-1032. PubMed ID: 27159742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Associated Preeclampsia: A Multifactorial Appraisal.
    Naicker T; Govender N; Abel T; Naidoo N; Moodley M; Pillay Y; Singh S; Khaliq OP; Moodley J
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502066
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.
    Suy A; Martínez E; Coll O; Lonca M; Palacio M; de Lazzari E; Larrousse M; Milinkovic A; Hernández S; Blanco JL; Mallolas J; León A; Vanrell JA; Gatell JM
    AIDS; 2006 Jan; 20(1):59-66. PubMed ID: 16327320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study.
    Boyajian T; Shah PS; Murphy KE
    J Obstet Gynaecol Can; 2012 Feb; 34(2):136-141. PubMed ID: 22340062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the complement system in HIV infection and preeclampsia.
    Pillay Y; Moodley J; Naicker T
    Inflamm Res; 2019 Jun; 68(6):459-469. PubMed ID: 31028431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the duration of HAART on cytokine profiles in pregnancy.
    Sebitloane HM; Naicker T; Moodley J
    Inflamm Res; 2020 Oct; 69(10):1053-1058. PubMed ID: 32638065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in sub-Saharan Africa.
    MacCarthy S; Laher F; Nduna M; Farlane L; Kaida A
    AIDS Behav; 2009 Jun; 13 Suppl 1():66-71. PubMed ID: 19301115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.